REFERENCES
2. Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol 2018;74:784-95.
3. Burger M, Oosterlinck W, Konety B, et al. ICUD-EAU international consultation on bladder cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013;63:36-44.
4. Rödel C, Grabenbauer GG, Kühn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002;20:3061-71.
5. Arcangeli G, Strigari L, Arcangeli S. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review of clinical trials. Crit Rev Oncol Hematol 2015;95:387-96.
6. Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 2021;79:82-104.
7. Witjes JA, Compérat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014;65:778-92.
8. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176:2414-22; discussion 2422.
9. Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 2018;73:925-33.
10. Thandapani S, Mahaboob MI, Iwendi C, et al. IoMT with deep CNN: AI-based intelligent support system for pandemic diseases. Electronics 2023;12:424.
11. Chou CY, Shu KH, Chen HC, et al. Development and validation of a nomogram for urothelial cancer in patients with chronic kidney disease. Sci Rep 2019;9:3473.
12. Pan Z, You H, Bu Q, et al. Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms’ tumor. J Cancer 2019;10:5299-305.
13. Wu S, Zheng J, Li Y, et al. A radiomics nomogram for the preoperative prediction of lymph node metastasis in bladder cancer. Clin Cancer Res 2017;23:6904-11.
14. Wang J, Wu Y, He W, Yang B, Gou X. Nomogram for predicting overall survival of patients with bladder cancer: a population-based study. Int J Biol Markers 2020;35:29-39.
15. Tao L, Pan X, Zhang L, et al. Marital status and prognostic nomogram for bladder cancer with distant metastasis: a SEER-based study. Front Oncol 2020;10:586458.
16. Novara G, De Marco V, Aragona M, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-21.
17. Schiffmann J, Gandaglia G, Larcher A, et al. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol 2014;40:1738-45.
18. Westergren DO, Gårdmark T, Lindhagen L, Chau A, Malmström PU. A nationwide, population based analysis of patients with organ confined, muscle invasive bladder cancer not receiving curative intent therapy in Sweden from 1997 to 2014. J Urol 2019;202:905-12.
19. Gospodarowicz MK, Rider WD, Keen CW, et al. Bladder cancer: long-term follow-up results of patients treated with radical radiation. Clin Oncol 1991;3:155-61.
20. Fosså SD, Wæhre H, Aass N, Jacobsen A, Olsen DR, Ous S. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer: a retrospective analysis of 317 patients. Cancer 1993;72:3036-43.
21. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005;104:1129-37.
22. Vinod SK, Hau E. Radiotherapy treatment for lung cancer: current status and future directions. Respirology 2020;25 Suppl 2:61-71.
23. Haussmann J, Corradini S, Nestle-Kraemling C, et al. Recent advances in radiotherapy of breast cancer. Radiat Oncol 2020;15:71.
24. Zaghloul MS, Christodouleas JP, Smith A, et al. Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial. JAMA Surg 2018;153:e174591.
25. Pignot G, Sargos P. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer. Prog Urol 2021;31:158-68.
26. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012;366:1477-88.
27. Reardon ZD, Patel SG, Zaid HB, et al. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol 2015;67:165-70.
28. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003;349:859-66.
29. Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist 2016;21:708-15.
30. Zargar H, Espiritu PN, Fairey AS, et al. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 2015;67:241-9.
31. Zargar H, Zargar-Shoshtari K, Lotan Y, et al. Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer-does pT0 predict Better survival than pTa/Tis/T1? J Urol 2016;195:886-93.
32. Huang C, Zhou W, Song P, Yuan N. Comparison of different prognostic models for predicting cancer-specific survival in bladder transitional cell carcinoma. Future Oncol 2019;15:851-64.
34. Rosiello G, Palumbo C, Deuker M, et al. Sex- and age-related differences in the distribution of bladder cancer metastases. Jpn J Clin Oncol 2021;51:976-83.
35. DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin 2019;69:211-33.
